Man Group
PFE icon

Man Group’s Pfizer PFE Stock Holding History

Man Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.32M Sell
345,400
-115,700
-25% -$3.03M 0.01% 878
2026
Q1 		$12.9M Buy
461,100
+456,500
+9,924% +$12.2M 0.02% 696
2025
Q4 		$115K Sell
4,600
-113,700
-96% -$2.87M ﹤0.01% 2184
2025
Q3 		$3.01M Sell
118,300
-329,300
-74% -$8.13M 0.01% 1264
2025
Q2 		$10.8M Buy
447,600
+77,200
+21% +$1.8M 0.02% 748
2025
Q1 		$9.39M Buy
370,400
+336,100
+980% +$8.79M 0.02% 754
2024
Q4 		$910K Sell
34,300
-103,800
-75% -$2.82M ﹤0.01% 1511
2024
Q3 		$4M Buy
138,100
+1,200
+0.9% +$35K 0.01% 1102
2024
Q2 		$3.83M Buy
136,900
+35,700
+35% +$983K 0.01% 1119
2024
Q1 		$2.81M Sell
101,200
-12,000
-11% -$333K 0.01% 1180
2023
Q4 		$3.26M Buy
+113,200
New +$3.42M 0.01% 1121

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Man Group's PFE Position: Q2 2026 in Review

Man Group reduced its Pfizer (PFE) stake by 7.4% in Q2 2026, selling an estimated $1.92M and leaving 912,739 shares worth $22M. The position accounts for 0.04% of the portfolio, ranked #475.

Man Group first reported a position in PFE in Q1 2018 and has held it in 31 quarters since. The position peaked at $117M in Q1 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Man Group held 912,739 shares of Pfizer worth $22M as of Q2 2026.
  • Man Group sold 73,382 Pfizer shares in Q2 2026, an estimated $1.92M.
  • Pfizer made up 0.04% of Man Group's portfolio in Q2 2026, its #475 holding.
  • Man Group first reported a position in Pfizer in Q1 2018 and has held it in 31 quarters since.
  • Man Group's Pfizer position peaked at $117M in Q1 2022.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.